what are the risks of tirzepatide promise tirzepatide: A narrative review of metabolic benefits Long-Term Safety of Tirzepatide: What

04, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate

If a store is even willing to sell them over the counter at all, thats a red flag that they might not be authentic

In addition, previous studies suggest GLP-1 drugs may directly inhibit a key mechanistic target of rapamycin (mTOR)-signaling pathway involved in tumor growth and proliferation

Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes